Developer docs
API playgroundTry for free, no card

Search company profiles

LifePlus

Full company profile

uuid0007ezf

Namestring
LifePlus
Legal namestring
LifePlus, Inc.
Websiteurl
lifeplus.ai
Company typeenum
Private
Founded yearint
2014
Descriptiontext

LifePlus, Inc. is a Silicon Valley-based private health technology company founded in 2014 (with its flagship product emerging from stealth in 2018) that develops the LifeLeaf non-invasive wrist-worn medical device and integrated software platform for continuous, multi-biomarker health monitoring. The hardware uses multi-sensor optical technology to measure blood glucose, blood pressure, heart rate, respiration rate, blood oxygen saturation, and steps without needles or cuffs, with reported clinical-grade accuracy of 10% MARD against BGM reference and cuff-comparable blood pressure readings validated in IRB-controlled multi-site studies. Data streams to a HIPAA-compliant cloud platform where proprietary AI/ML algorithms — trained on 70,000+ paired data points from 500+ subjects — generate actionable health insights delivered through a mobile app (iOS and Android), a patient user portal, and a caregiver portal for healthcare providers.

The company monetizes through a hybrid model: one-time hardware sales of the LifeLeaf smartwatch combined with recurring monthly SaaS subscription fees for the platform, app, and caregiver portal, with a stated intent to also capture revenue via remote patient monitoring reimbursement programs. Go-to-market is omnichannel: direct-to-consumer via the LifePlus website and mobile app stores, paired with a rapidly expanding network of strategic distribution partnerships that now place LifeLeaf in 27 countries across the EU (13), MENA (4), and APAC (12). Primary customer segments are patients with chronic conditions such as Type 2 diabetes, hypertension, COPD, atrial fibrillation, and sleep apnea, along with their healthcare providers and care teams; secondary segments include homecare/consumer wellness users and academic/research institutions conducting clinical studies on the platform.

Operationally, LifePlus is venture-backed and privately held, led by co-founders Alodeep Sanyal, PhD (CEO, ex-Intel) and Ben Mbouombouo (COO, 30+ issued USPTO patents), with a Chief Scientific Officer (Nilanjan Banerjee), Chief Medical Officer (Indranil Sen-Gupta), and a Medical Advisory Board spanning endocrinology, cardiology, and interventional cardiology. The IP estate comprises 13+ granted US patents covering non-invasive glucose concentration determination, tissue state classification, and adaptive monitoring ecosystems, with additional applications pending. No revenue, funding rounds, or institutional investor names are disclosed in the available material.

Short descriptiontext

LifePlus builds the LifeLeaf non-invasive smartwatch and AI-driven platform that continuously monitor blood glucose, blood pressure, heart rate, and other biomarkers, serving chronic disease patients, healthcare providers, and caregivers across 27 countries via D2C and channel partnerships.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Jose, United States
HQ citystring
San Jose
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
non-invasive health monitoring, continuous glucose monitoring, wearable biosensor devices, remote patient monitoring, AI-driven health insights
Industry4 codes
PRIMARYCRACAQAE
Blood Glucose Monitoring Devices (Consumer CGM & Smart Glucometers)
Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)
SECONDARYCRACAQAB
Blood Pressure Monitors (Smart Cuffs)
Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)
SECONDARYCRAKADAC
Smartwatches & Connected Wearables
SECONDARYCRACAQAF
Pulse Oximeters & Respiratory Monitors (Consumer)
Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Wearable Health Monitoring Devices
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Hardware Sales (LifeLeaf Smartwatch)
TypeHardware Sales
Description

LifePlus sells the LifeLeaf smartwatch as a one-time hardware purchase. The device is a single piece of hardware with no ongoing consumables (no needles, sensors, or finger sticks required).

lifeplus.ai
2SaaS Subscription Services
TypeSubscription Recurring
Description

LifePlus provides subscription services including the web portal, mobile app, and SaaS services accessible using the smartwatch product. Recurring monthly subscription charges apply for paid account types. Fees are auto-charged to the payment method on file, monthly until cancelled. All fees in USD and non-refundable. Cancellation requires 30-day notice.

lifeplus.ai
3Remote Patient Monitoring Reimbursement
TypeManaged Services
Description

LifeLeaf delivers seamless capture, retention and presentation of health data to ensure maximum reimbursement under healthcare reimbursement programs. The homecare segment is expected to dominate the non-invasive blood glucose monitoring market by end-user.

globenewswire.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Subscription-based SaaS with recurring monthly fees for access to the LifeLeaf platform, app, and caregiver portal.
ModelSubscriptionBilling cadenceMonthly
Notes

Fees displayed at account creation. All fees in USD and non-refundable. Fees may be modified with 30 days notice. Cancellation requires 30 days prior notice.

lifeplus.ai
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1LifeLeaf
Description

World's first non-invasive device and platform that measures key health markers including blood glucose and blood pressure. A wrist-worn wearable device with AI-driven real-time health insights for continuous monitoring of chronic care biomarkers.

lifeplus.ai
+1 more record
Core offering1 text field

LifePlus develops and sells the LifeLeaf smartwatch, a wrist-worn non-invasive wearable that continuously measures blood glucose, blood pressure, heart rate, respiration rate, blood oxygen saturation, and steps using optical biosensors. The device pairs with a HIPAA-compliant cloud platform, a mobile application (iOS/Android), a patient user portal, and a caregiver portal that delivers AI/ML-driven insights for chronic care and remote patient monitoring. The company sells the hardware as a one-time purchase and offers the platform as a recurring monthly SaaS subscription.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Glucose readings within 10% MARD against BGM reference
+5 more records
Product overview1 text field

LifePlus offers the LifeLeaf and GlucoNow continuous health monitoring wearable products, all powered by the LIFELEAF® non-invasive continuous vital signs monitoring system. The portfolio consists of the LifeLeaf wrist-worn wearable device as the core hardware product, paired with the LifeLeaf Mobile Application (iOS/Android), LifeLeaf User Portal for patients, and LifeLeaf Caregiver Portal for healthcare providers. All devices connect to a HIPAA-compliant cloud platform that applies AI/ML algorithms to health data. GlucoNow is a secondary brand variant operating on the same platform.

Product and service6 records
1LifeLeaf Smartwatch
CategoryWearable biosensor hardware
Description

World's first non-invasive wrist-worn medical device that continuously monitors blood glucose, blood pressure, heart rate, respiration rate, blood oxygen saturation, steps, and meals using optical sensors, without needles or cuffs. Sold as a one-time hardware purchase to consumers and to healthcare provider programs for chronic care and remote patient monitoring.

2LifeLeaf Mobile Application
CategoryCompanion software application
Description

Companion mobile app for iOS and Android that displays health data, trends, AI-driven insights, and alerts from the LifeLeaf smartwatch. Provides step-by-step user guide, pairing instructions, and firmware updates for end users.

3LifeLeaf User Portal
CategoryWeb portal for patients
Description

Web-based portal where individual patients can view long-term health trends and detailed health records from anywhere, accessible using their LifeLeaf account.

4LifeLeaf Caregiver Portal
CategoryWeb portal for care teams
Description

Web portal allowing healthcare care teams, family caregivers, and providers to view real-time patient health trends and engage in proactive care management for remote patient monitoring programs.

5LifeLeaf Cloud Platform
CategoryCloud-based health analytics SaaS
Description

HIPAA-compliant cloud storage and analytics platform that streams health data from the LifeLeaf wearable device and applies AI/ML algorithms to generate actionable health insights, with seamless integration for third-party data sources such as EHR, lifestyle, nutrition, and fitness applications.

6GlucoNow
CategorySub-brand wearable product
Description

Continuous health monitoring wearable product powered by the LIFELEAF non-invasive continuous vital signs monitoring system, functioning as a secondary brand variant of LifeLeaf targeting glucose monitoring use cases.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-06-03
Description

LifePlus announced rapid global commercial expansion through new strategic partnerships across Europe, Asia, and the Middle East in June 2025. These partnerships cover distribution and commercial presence across 27 countries including EU states (Germany, Netherlands, Spain, etc.), MENA (UAE, Saudi Arabia), and APAC (Japan, Australia, India, Singapore). The expansion follows growing demand for LifeLeaf as the world's first non-invasive continuous glucose monitoring wearable.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Dexcom is the dominant FDA-cleared continuous glucose monitor maker (G6, G7) serving people with diabetes. LifePlus competes in the same CGM use case with a non-invasive optical approach vs. Dexcom's subcutaneous sensor.

2Abbott (FreeStyle Libre)
TypeDirect peer
Description

Abbott's FreeStyle Libre is the world's highest-volume CGM (Libre 2, Libre 3) and the standard for non-insulin and insulin-using diabetes patients. LifePlus targets the same use case with a needle-free smartwatch instead of an arm-worn sensor patch.

TypeDirect peer
Description

Medtronic offers Guardian and Simplera CGM systems integrated with its insulin pumps. Like LifePlus, it pursues continuous glucose monitoring for chronic disease management, though via invasive subcutaneous sensors rather than optical.

TypeBroad incumbent
Description

Apple Watch provides HR, SpO2, ECG, and irregular rhythm notifications via FDA-cleared features, and is the dominant consumer smartwatch form factor. LifePlus competes for wrist-based health monitoring real estate but specializes in CGM/BP rather than general-purpose smartwatch functionality.

TypeBroad incumbent
Description

Fitbit (now part of Google) offers multi-day smartwatches and trackers with HR, SpO2, ECG, sleep, and irregular rhythm features. It competes with LifePlus on the consumer wellness smartwatch use case but does not target non-invasive CGM or BP.

TypeEmerging player
Description

Oura sells the Oura Ring for continuous sleep, HR, temperature, and readiness monitoring with a subscription model. Comparable to LifePlus's recurring SaaS + wearable bundle, though ring-form-factor and no glucose/BP capability.

TypeEmerging player
Description

Withings offers connected health devices (BPM Core, Body Scan, ScanWatch) covering blood pressure, ECG, sleep, and SpO2. Comparable to LifePlus on multi-biomarker home monitoring with cloud platform, but does not offer non-invasive glucose.

TypeBroad incumbent
Description

Garmin produces health-tracking smartwatches (Venu, fēnix, Forerunner) with HR, SpO2, sleep, and stress features plus long battery life. Comparable wrist-based health monitoring competitor without glucose/BP focus.

TypeEmerging player
Description

BioIntellisense offers the BioSticker and BioButton for continuous multi-parameter wearable monitoring and remote patient monitoring services. Comparable to LifePlus's RPM enterprise motion for healthcare providers.

TypeEmerging player
Description

Empatica makes the FDA-cleared EpiMonitor (Embrace) for seizure detection and continuous physiological monitoring. Comparable medical-grade wearable + AI platform targeting chronic neurological and physiological conditions, with overlapping clinical/regulatory positioning.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

LifePlus

Wearable Health Monitoring Deviceslifeplus.ai

LifePlus builds the LifeLeaf non-invasive smartwatch and AI-driven platform that continuously monitor blood glucose, blood pressure, heart rate, and other biomarkers, serving chronic disease patients, healthcare providers, and caregivers across 27 countries via D2C and channel partnerships.

What LifePlus does

LifePlus, Inc. is a Silicon Valley-based private health technology company founded in 2014 (with its flagship product emerging from stealth in 2018) that develops the LifeLeaf non-invasive wrist-worn medical device and integrated software platform for continuous, multi-biomarker health monitoring. The hardware uses multi-sensor optical technology to measure blood glucose, blood pressure, heart rate, respiration rate, blood oxygen saturation, and steps without needles or cuffs, with reported clinical-grade accuracy of 10% MARD against BGM reference and cuff-comparable blood pressure readings validated in IRB-controlled multi-site studies. Data streams to a HIPAA-compliant cloud platform where proprietary AI/ML algorithms — trained on 70,000+ paired data points from 500+ subjects — generate actionable health insights delivered through a mobile app (iOS and Android), a patient user portal, and a caregiver portal for healthcare providers.

The company monetizes through a hybrid model: one-time hardware sales of the LifeLeaf smartwatch combined with recurring monthly SaaS subscription fees for the platform, app, and caregiver portal, with a stated intent to also capture revenue via remote patient monitoring reimbursement programs. Go-to-market is omnichannel: direct-to-consumer via the LifePlus website and mobile app stores, paired with a rapidly expanding network of strategic distribution partnerships that now place LifeLeaf in 27 countries across the EU (13), MENA (4), and APAC (12). Primary customer segments are patients with chronic conditions such as Type 2 diabetes, hypertension, COPD, atrial fibrillation, and sleep apnea, along with their healthcare providers and care teams; secondary segments include homecare/consumer wellness users and academic/research institutions conducting clinical studies on the platform.

Operationally, LifePlus is venture-backed and privately held, led by co-founders Alodeep Sanyal, PhD (CEO, ex-Intel) and Ben Mbouombouo (COO, 30+ issued USPTO patents), with a Chief Scientific Officer (Nilanjan Banerjee), Chief Medical Officer (Indranil Sen-Gupta), and a Medical Advisory Board spanning endocrinology, cardiology, and interventional cardiology. The IP estate comprises 13+ granted US patents covering non-invasive glucose concentration determination, tissue state classification, and adaptive monitoring ecosystems, with additional applications pending. No revenue, funding rounds, or institutional investor names are disclosed in the available material.

LifePlus firmographics

Firmographics
Name
LifePlus
Legal name
LifePlus, Inc.
Website
https://lifeplus.ai
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
11–50 employees
Short description
LifePlus builds the LifeLeaf non-invasive smartwatch and AI-driven platform that continuously monitor blood glucose, blood pressure, heart rate, and other biomarkers, serving chronic disease patients, healthcare providers, and caregivers across 27 countries via D2C and channel partnerships.
Ownership category
akta.pro rank

LifePlus industry classification

Industry
Product category
Wearable Health Monitoring Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYCRACAQAE
Blood Glucose Monitoring Devices (Consumer CGM & Smart Glucometers)
Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)
SECONDARYCRACAQAB
Blood Pressure Monitors (Smart Cuffs)
Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)
SECONDARYCRAKADAC
Smartwatches & Connected Wearables
SECONDARYCRACAQAF
Pulse Oximeters & Respiratory Monitors (Consumer)
Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)

Keywords

  • Non-invasive health monitoring
  • Continuous glucose monitoring
  • Wearable biosensor devices
  • Remote patient monitoring
  • AI-driven health insights

Where LifePlus is headquartered

Location

Headquarters

HQ city
San Jose
HQ country
United States
HQ region
North America

Offices1 record

Markets served

LifePlus business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Hardware Sales (LifeLeaf Smartwatch): LifePlus sells the LifeLeaf smartwatch as a one-time hardware purchase. The device is a single piece of hardware with no ongoing consumables (no needles, sensors, or finger sticks required).
  2. SaaS Subscription Services: LifePlus provides subscription services including the web portal, mobile app, and SaaS services accessible using the smartwatch product. Recurring monthly subscription charges apply for paid account types. Fees are auto-charged to the payment method on file, monthly until cancelled. All fees in USD and non-refundable. Cancellation requires 30-day notice.
  3. Remote Patient Monitoring Reimbursement: LifeLeaf delivers seamless capture, retention and presentation of health data to ensure maximum reimbursement under healthcare reimbursement programs. The homecare segment is expected to dominate the non-invasive blood glucose monitoring market by end-user.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlySubscription-based SaaS with recurring monthly fees for access to the LifeLeaf platform, app, and caregiver portal.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

LifePlus product offering

Product offering

Core offering

LifePlus develops and sells the LifeLeaf smartwatch, a wrist-worn non-invasive wearable that continuously measures blood glucose, blood pressure, heart rate, respiration rate, blood oxygen saturation, and steps using optical biosensors. The device pairs with a HIPAA-compliant cloud platform, a mobile application (iOS/Android), a patient user portal, and a caregiver portal that delivers AI/ML-driven insights for chronic care and remote patient monitoring. The company sells the hardware as a one-time purchase and offers the platform as a recurring monthly SaaS subscription.

Product overview

LifePlus offers the LifeLeaf and GlucoNow continuous health monitoring wearable products, all powered by the LIFELEAF® non-invasive continuous vital signs monitoring system. The portfolio consists of the LifeLeaf wrist-worn wearable device as the core hardware product, paired with the LifeLeaf Mobile Application (iOS/Android), LifeLeaf User Portal for patients, and LifeLeaf Caregiver Portal for healthcare providers. All devices connect to a HIPAA-compliant cloud platform that applies AI/ML algorithms to health data. GlucoNow is a secondary brand variant operating on the same platform.

Differentiator

Problem solved

Functional benefit

Brands

  • LifeLeaf: World's first non-invasive device and platform that measures key health markers including blood glucose and blood pressure. A wrist-worn wearable device with AI-driven real-time health insights for continuous monitoring of chronic care biomarkers.
  • LIFELEAF

Products and services

  • LifeLeaf Smartwatch World's first non-invasive wrist-worn medical device that continuously monitors blood glucose, blood pressure, heart rate, respiration rate, blood oxygen saturation, steps, and meals using optical sensors, without needles or cuffs. Sold as a one-time hardware purchase to consumers and to healthcare provider programs for chronic care and remote patient monitoring.
  • LifeLeaf Mobile Application Companion mobile app for iOS and Android that displays health data, trends, AI-driven insights, and alerts from the LifeLeaf smartwatch. Provides step-by-step user guide, pairing instructions, and firmware updates for end users.
  • LifeLeaf User Portal Web-based portal where individual patients can view long-term health trends and detailed health records from anywhere, accessible using their LifeLeaf account.
  • LifeLeaf Caregiver Portal Web portal allowing healthcare care teams, family caregivers, and providers to view real-time patient health trends and engage in proactive care management for remote patient monitoring programs.
  • LifeLeaf Cloud Platform HIPAA-compliant cloud storage and analytics platform that streams health data from the LifeLeaf wearable device and applies AI/ML algorithms to generate actionable health insights, with seamless integration for third-party data sources such as EHR, lifestyle, nutrition, and fitness applications.
  • GlucoNow Continuous health monitoring wearable product powered by the LIFELEAF non-invasive continuous vital signs monitoring system, functioning as a secondary brand variant of LifeLeaf targeting glucose monitoring use cases.

Quantifiable outcome

  • Glucose readings within 10% MARD against BGM reference
  • +5 more outcomes

Companies that use LifePlus

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

LifePlus technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability7 records

Feature7 records

LifePlus partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Strategic Partners (Europe, Asia, Middle East)coreChannel Partner/ Reseller/ Distributor · 3 June 2025LifePlus announced rapid global commercial expansion through new strategic partnerships across Europe, Asia, and the Middle East in June 2025. These partnerships cover distribution and commercial presence across 27 countries including EU states (Germany, Netherlands, Spain, etc.), MENA (UAE, Saudi Arabia), and APAC (Japan, Australia, India, Singapore). The expansion follows growing demand for LifeLeaf as the world's first non-invasive continuous glucose monitoring wearable.

Scale indicators7 records

Recent moves7 records

Expansion highlights5 records

LifePlus competitors and assessment

Company assessment

Direct peers

  • Dexcom: Dexcom is the dominant FDA-cleared continuous glucose monitor maker (G6, G7) serving people with diabetes. LifePlus competes in the same CGM use case with a non-invasive optical approach vs. Dexcom's subcutaneous sensor.
  • Abbott (FreeStyle Libre): Abbott's FreeStyle Libre is the world's highest-volume CGM (Libre 2, Libre 3) and the standard for non-insulin and insulin-using diabetes patients. LifePlus targets the same use case with a needle-free smartwatch instead of an arm-worn sensor patch.
  • Medtronic (Guardian Connect / Simplera): Medtronic offers Guardian and Simplera CGM systems integrated with its insulin pumps. Like LifePlus, it pursues continuous glucose monitoring for chronic disease management, though via invasive subcutaneous sensors rather than optical.

Broad incumbents

  • Apple (Apple Watch): Apple Watch provides HR, SpO2, ECG, and irregular rhythm notifications via FDA-cleared features, and is the dominant consumer smartwatch form factor. LifePlus competes for wrist-based health monitoring real estate but specializes in CGM/BP rather than general-purpose smartwatch functionality.
  • Fitbit (Google): Fitbit (now part of Google) offers multi-day smartwatches and trackers with HR, SpO2, ECG, sleep, and irregular rhythm features. It competes with LifePlus on the consumer wellness smartwatch use case but does not target non-invasive CGM or BP.
  • Garmin: Garmin produces health-tracking smartwatches (Venu, fēnix, Forerunner) with HR, SpO2, sleep, and stress features plus long battery life. Comparable wrist-based health monitoring competitor without glucose/BP focus.

Emerging players

  • Oura: Oura sells the Oura Ring for continuous sleep, HR, temperature, and readiness monitoring with a subscription model. Comparable to LifePlus's recurring SaaS + wearable bundle, though ring-form-factor and no glucose/BP capability.
  • Withings: Withings offers connected health devices (BPM Core, Body Scan, ScanWatch) covering blood pressure, ECG, sleep, and SpO2. Comparable to LifePlus on multi-biomarker home monitoring with cloud platform, but does not offer non-invasive glucose.
  • BioIntellisense: BioIntellisense offers the BioSticker and BioButton for continuous multi-parameter wearable monitoring and remote patient monitoring services. Comparable to LifePlus's RPM enterprise motion for healthcare providers.
  • Empatica: Empatica makes the FDA-cleared EpiMonitor (Embrace) for seizure detection and continuous physiological monitoring. Comparable medical-grade wearable + AI platform targeting chronic neurological and physiological conditions, with overlapping clinical/regulatory positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

LifePlus social profiles

Digital presence

LifePlus financial estimates

Financial estimate

Revenue estimate

Valuation estimate

LifePlus leadership team

Management profile

Number of profiles

Profiles12 records

LifePlus funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

LifePlus M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LifePlus

What does LifePlus do?

LifePlus develops and sells the LifeLeaf smartwatch, a wrist-worn non-invasive wearable that continuously measures blood glucose, blood pressure, heart rate, respiration rate, blood oxygen saturation, and steps using optical biosensors. The device pairs with a HIPAA-compliant cloud platform, a mobile application (iOS/Android), a patient user portal, and a caregiver portal that delivers AI/ML-driven insights for chronic care and remote patient monitoring. The company sells the hardware as a one-time purchase and offers the platform as a recurring monthly SaaS subscription.

Is LifePlus a public or private company?

LifePlus is a private company. It is classified as venture growth investor backed and is currently operating.

When was LifePlus founded?

LifePlus was founded in 2014. It employs 11 to 50 people.

Where is LifePlus based?

LifePlus is headquartered in San Jose, United States, in the North America region.

How does LifePlus make money?

Three revenue lines are on record. Hardware Sales (LifeLeaf Smartwatch) is the primary driver. The others are saaS Subscription Services and remote Patient Monitoring Reimbursement.

Who are LifePlus's main competitors?

Direct peers on record are Dexcom, Abbott (FreeStyle Libre) and Medtronic (Guardian Connect / Simplera). Broad incumbents are Apple (Apple Watch), Fitbit (Google) and Garmin. Emerging players are Oura, Withings, BioIntellisense and Empatica.

Does LifePlus have an API?

No public API is recorded for LifePlus.

What industry is LifePlus in?

LifePlus's product category is Wearable Health Monitoring Devices. Its primary akta.pro industry code is CRACAQAE, Blood Glucose Monitoring Devices (Consumer CGM & Smart Glucometers), with a secondary code of CRACAQAB, Blood Pressure Monitors (Smart Cuffs). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Wire BlogLifePlus Establishes Global Clinical Validation for First-of-Its-Kind Non-Invasive Glucose and Cuffless BP Monitoring Device and PlatformLifePlus announced clinical validation of LifeLeaf, a non-invasive wristwatch for continuous glucose and blood pressure monitoring, tested at Mayo Clinic and Cleveland Clinic. The device achieved 10.8% MARD against BGM and cuffless BP accuracy of –0.02 ± 12.5 mmHg, with results to be presented at the ADA meeting in June 2025.Business Wire BlogLifePlus Scales Global Commercial Presence with Strategic Partnerships Across Europe, Asia, and Middle EastLifePlus announced global expansion through new partnerships across Europe, Asia, and the Middle East, following demand for its LifeLeaf wrist-worn medical device. The device has over 100,000 units ordered and over 10 distribution agreements signed, with early pilots in multiple countries. LifePlus is onboarding new distribution partners and pursuing formal regulatory authorization.YahooLifePlus Scales Global Commercial Presence with Strategic Partnerships Across Europe, Asia, and Middle EastLifePlus announced global expansion through new partnerships across Europe, Asia, and the Middle East, following strong demand for its LifeLeaf device. The wrist-worn monitor has over 100,000 units ordered, with over 10 distribution agreements signed and early pilots in multiple countries. The company is pursuing formal regulatory authorization from FDA, CE, and other authorities.PR NewswireLittle kickers joins forces with Lifeplus, a leading light in wellnessLittle Kickers and Lifeplus announced a sponsorship alliance in September 2022, with Lifeplus sponsoring Little Kickers' football kits and balls. The partnership supports Little Kickers' shift to sustainable fabrics made from ocean-harvested plastic, and Little Kickers serves 70,000 children across 34+ countries.